GlassScriptPhysician profile
Mark P Weintraub
NPI 1053342386
$7,378.79
in general payments reported to CMS, 2019-2025
44 companies · $2,810 in 2025
The $2,810 reported for 2025 was more than what 86% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $756 · 2020: $151 · 2021: $533 · 2022: $1,185 · 2023: $949 · 2024: $996 · 2025: $2,810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,411 · Travel and Lodging: $245 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,411.00 |
| Travel and Lodging | $244.52 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,190.08 | 2021-2024 | Axonics |
| Janssen Biotech, INC. | $673.46 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Teleflex LLC | $481.10 | 2022-2025 | Barrigel, Urolift |
| Procept Biorobotics Corporation | $389.53 | 2022-2025 | |
| Karl Storz Endoscopy-America | $337.17 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $313.88 | 2019-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $311.10 | 2019-2025 | |
| Coloplast Corp | $298.59 | 2020-2025 | |
| Rochester Medical Corporation | $298.17 | 2019-2021 | |
| Dornier Medtech America, INC | $287.53 | 2025 | Dornier Medtech |
| Astellas Pharma US INC | $286.99 | 2019-2023 | Myrbetriq |
| Endo Pharmaceuticals INC. | $257.16 | 2019-2024 | Aveed, Edex, Xiaflex |
| Laborie Medical Technologies Corp. | $230.65 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Sumitomo Pharma America, INC. | $182.62 | 2023-2025 | Gemtesa, Orgovyx |
| Olympus America INC. | $180.59 | 2022-2025 | Itind System |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocompatibles, INC. | $148.24 | 2019 | |
| Boston Scientific Corporation | $148.07 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 700 |
| Endo USA, INC. | $141.43 | 2024-2025 | Xiaflex, Aveed, Edex |
| Novartis Pharmaceuticals Corporation | $118.53 | 2022-2025 | |
| Bluewind Medical | $103.22 | 2025 | |
| 180 Medical, INC. | $82.35 | 2022-2023 | Gentlecath |
| Urogen Pharma, INC. | $81.42 | 2024-2025 | |
| Accord Healthcare, INC. | $71.49 | 2025 | |
| Abbvie INC. | $70.55 | 2022-2024 | Botox |
| Verity Pharmaceuticals INC. | $59.04 | 2022-2024 | Trelstar |
| Tolmar, INC. | $57.86 | 2023-2025 | Eligard |
| Medtronic, INC. | $57.20 | 2023-2025 | Interstim |
| Neotract INC. | $53.33 | 2019-2020 | |
| Baxter Healthcare | $44.55 | 2024 | Tisseel |
| Janssen Scientific Affairs, LLC | $44.31 | 2025 | Erleada |
| Bioprotect Medical, INC. | $42.55 | 2024-2025 | Bioprotect Balloon Implant System |
| Civco Medical Instruments | $39.70 | 2024 | |
| Immunitybio, INC. | $39.55 | 2025 | |
| Myovant Sciences INC. | $38.89 | 2021-2022 | |
| Pfizer INC. | $37.92 | 2019-2025 | |
| Tolmar Pharmaceuticals, INC. | $36.79 | 2019-2022 | |
| Hollister Incorporated | $31.39 | 2023 | Infyna Chic, Vapro Plus Pocket |
| Astrazeneca Pharmaceuticals LP | $20.75 | 2024 | Lynparza |
| Antares Pharma, INC. | $19.62 | 2019 | |
| Urovant Sciences INC | $18.59 | 2021 | |
| Amgen INC. | $14.06 | 2019 | |
| Angiodynamics, INC. | $13.26 | 2023 | Nanoknife |
| Myriad Genetic Laboratories, INC. | $12.88 | 2021 | |
| Therapeuticsmd, INC. | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Weintraub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.